Further, our study validated the approach of utilizing a plasmid DNA (encoding for a specific shRNA) to silence a target gene (i.e. Cdk2), disrupt the cell cycle and negatively regulate the proliferation of cancer cells (MCF-7), ultimately, leading to cell death. This evidence concerns the gene CDK2 and cancer.